While the last decade brought breakthroughs for some bleeding disorders, over 500,000 people with overlooked conditions continue waiting for innovation. These patients have normalized living with unpredictable bleeds, limiting their activities and independence. At Hemab, we believe a different future is possible—one where prevention, not just management, becomes the standard of care. But first, we need to rewrite these overlooked stories.